|
Market Closed -
Nasdaq
00:00:00 03/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.140 USD | -7.15% |
|
-10.41% | +7.37% |
| 10-01 | Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes | CI |
| 08-06 | Evolus, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 472M | - | ||||
| 1,019B | |||||
| 617B | - | ||||
| 464B | |||||
| 356B | |||||
| 333B |
- Stock Market
- Stocks
- EOLS Stock
- Charts Evolus, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
